Sun Pharmaceutical Industries Ltd. Stock price

Equities

SUNPHARMA

INE044A01036

Pharmaceuticals

Delayed NSE India S.E. 05:42:24 2024-03-19 am EDT 5-day change 1st Jan Change
1,549 INR -1.42% Intraday chart for Sun Pharmaceutical Industries Ltd. -2.23% +22.99%
Sales 2024 * 485B 5.86B Sales 2025 * 538B 6.49B Capitalization 3,770B 45.47B
Net income 2024 * 93.12B 1.12B Net income 2025 * 113B 1.36B EV / Sales 2024 * 7.54 x
Net cash position 2024 * 108B 1.31B Net cash position 2025 * 166B 2B EV / Sales 2025 * 6.69 x
P/E ratio 2024 *
40.6 x
P/E ratio 2025 *
33.5 x
Employees 41,000
Yield 2024 *
0.77%
Yield 2025 *
0.89%
Free-Float 45.32%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.07%
1 week-0.89%
Current month-0.49%
1 month+2.62%
3 months+26.12%
6 months+36.16%
Current year+24.67%
More quotes
1 week
1 541.20
Extreme 1541.2
1 592.20
1 month
1 512.25
Extreme 1512.25
1 627.00
Current year
1 257.15
Extreme 1257.15
1 627.00
1 year
922.45
Extreme 922.45
1 627.00
3 years
571.50
Extreme 571.5
1 627.00
5 years
312.00
Extreme 312
1 627.00
10 years
312.00
Extreme 312
1 627.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Founder 68 81-12-31
Director of Finance/CFO - 17-06-18
Members of the board TitleAgeSince
Founder 68 81-12-31
Director/Board Member 67 21-05-20
Director/Board Member 63 23-06-14
More insiders
Date Price Change Volume
24-03-19 1,549 -1.42% 3 293 881
24-03-18 1,571 +1.49% 2,281,873
24-03-15 1,548 -1.40% 3,421,374
24-03-14 1,570 +0.74% 3,062,556
24-03-13 1,559 -1.62% 2,881,503

Delayed Quote NSE India S.E., March 19, 2024 at 03:39 am EDT

More quotes
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants worldwide. Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
37
Last Close Price
1,571 INR
Average target price
1,538 INR
Spread / Average Target
-2.13%
Consensus
  1. Stock
  2. Equities
  3. Stock Sun Pharmaceutical Industries Ltd. - NSE India S.E.